Wegovy May Reduce the Risk of Death From COVID-19, Study Suggests
People without diabetes taking Wegovy (semaglutide) for weight loss were less likely to die of COVID-19 during the pandemic, a large new study found. Although the anti-obesity drug didn’t protect…